| Primary information |
|---|
| sequence ID | Seq_1207 |
| Peptide sequence | DEAGSEADHEGTHSTKRGHAKSRP |
| CancerPDF_ID | CancerPDF_ID3755, CancerPDF_ID8537, CancerPDF_ID10599, |
| PMID | 27026199,23667664,21805675 |
| Protein Name | "Fibrinogen alpha chain, Fibrinogen alpha chain",Fibrinogen alpha,Fibrinogen alpha chain |
| UniprotKB Entry Name | FIBA_HUMAN,FIBA_HUMAN,FIBA_HUMAN |
| Fluid | Urine,Serum,Urine |
| M/Z | NA,2559.18,2560.1784 |
| Charge | NA,1,NA |
| Mass (in Da) | NA,2561.65,NA |
| fdr | 2559.18,NA,NA |
| Profiling Technique | "CE-MS, Micro-TOF-MS",MALDI-TOF,MALDI-TOF |
| Peptide Identification technique | MS-MS,FT-ICR MS/MS + nano-HPLC,MALDI-TOF-MS |
| Quantification Technique | NA,NA,NA |
| Labelled/Label Free | Label Free,Label Free,Label Free |
| FDR | NA,NA,1 |
| CancerPDF_ID | CancerPDF_ID3755, CancerPDF_ID8537, CancerPDF_ID10599, |
| p-Value | less than 0.01,NA,NA |
| Software | Proteome Discoverer 1.2,MASCOT,NA |
| Length | 24,24,24 |
| Cancer Type | Bladder cancer,"Breast cancer, Lung cancer, Rectal cancer",Muscle-invasive bladder cancer |
| Database | Uniprot Human non-redundant Database,NA,SwissProt Database |
| Modification | NA,NA,NA |
| Number of Patients | 425 for training(109 patients with Recurrent UBC cases and 316 negative for recurrence controls) and 211 for validation (55 UBC recurrent cases and 156 recurrent controls),"Breast Cancer =84, lung cancer= 70, Rectal cancer = 30patients; 500 healthy",751 bladder cancer and 127 control |
| Regulation | Differentially expressed between recurrence of UBC vs recurrence control,NA,Differentially expressed between cancer vs normal samples |
| Validation | Independent Validation,NA,Mann-Whitney tests and areas under receiver-operator characteristic |
| Sensitivity | For testing dataset 88%,NA,NA |
| Specificity | For testing dataset 51%,NA,NA |
| Accuracy | NA,NA,NA |
| Peptide Atlas | NA |
| IEDB | |